Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACY-1215 in Relapsed/Refractory Lymphoid Malignancies
NCT02091063Phase 2Terminated
- Start
- Apr 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ricolinostat in lymphoid malignancy. Started Apr 2014; status: terminated.
02
Drugs
ricolinostat
03
Conditions
lymphoid malignancy
Beyond the preview
Go deeper on NCT02091063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091063.